Outcomes for patients who develop both breast and colorectal cancer

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 242-248

  Fisher, Carla S ^a   Wachtel, Mitchell S ^b   Margenthaler, Julie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADENOCARCINOMA; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE;

EID: 84856685484     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1843-8     Document Type: Article

References (15)

1. Prevention Center for Disease Control and Cancer Among Women. http://www.cdc.gov/cancer/dcpc/data/women.htm. Accessed 18 Feb 2011.
2. National Cancer Institute: Surveillance Epidemiology, and End Results. Overview of the SEER Program. http://seer.cancer.gov/about/. Accessed 11 Feb 2011.
3. Aging Department of Health and Human Services: Administration of Aging Statistics. http://www.aoa.gov/aoaroot/aging-statistics/index.aspx. Accessed 18 Feb 2011.
4. W Lu M Schaapveld L Jansen E Bagherzadegan MM Sahinovic PC Baas, et al. 2009 The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer Eur J Cancer 45 3000 3007 19744851 10.1016/j.ejca.2009.08.007
5. Y Chen W Thompson R Semenciw Y Mao 1999 Epidemiology of contralateral breast cancer Cancer Epidemiol Biomarkers Prev 8 855 861 10548312 1:STN:280:DC%2BD3c%2FhsVenug%3D%3D
6. JL Bernstein RH Lapinski SS Thakore J Doucette WD Thompson 2003 The descriptive epidemiology of second primary breast cancer Epidemiology 14 552 558 14501270 10.1097/01.ede.0000072105.39021.6d
7. DE Heron LT Komarnicky T Hyslop GF Schwartz CM Mansfield 2000 Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease Cancer 88 2739 2750 10870056 10.1002/1097-0142(20000615)88: 12<2739::AID-CNCR12>3.0.CO;2-J 1:STN:280:DC%2BD3czivFymtw%3D%3D
8. JB Bernstein WD Thompson N Risch TR Holford 1992 Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer Am J Epidemiol 136 925 936 1456269 1:STN:280: DyaK3s%2FovFehsw%3D%3D
9. CI Li KE Malone PL Porter JR Daling 2003 Epidemiologic and molecular risk factors for contralateral breast cancer among young women Br J Cancer 89 513 518 12888823 10.1038/sj.bjc.6601042 1:STN:280:DC%2BD3szlsFanug%3D%3D
10. Diaz R, Munarriz B, Santaballa A, Palomar L, Montalar J. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience. Med Oncol. 2010. doi: 10.1007/s12032-010-9785-8.
11. M Hartman K Czene M Reilly J Adolfsson J Bergh HO Adami, et al. 2007 Incidence and prognosis of synchronous and metachronous bilateral breast cancer J Clin Oncol 25 4210 4216 17878475 10.1200/JCO.2006.10.5056
12. AM Bouvier M Latournerie V Jooste C Lepage V Cottet J Faivre 2008 The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up Eur J Cancer 44 522 527 18255278 10.1016/j.ejca.2008.01.007
13. JA Chapman D Meng L Shepherd W Parulekar JN Ingle HB Muss, et al. 2008 Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer J Natl Cancer Inst 100 252 260 18270335 10.1093/jnci/djn014
14. G Rennert M Pinchev HS Rennert SB Gruber 2011 Use of bisphosphonates and reduced risk of colorectal cancer J Clin Oncol 29 1146 1150 21321296 10.1200/JCO.2010.33.7485
15. RM Merrill KA Dearden 2004 How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States Cancer Cause Control 15 1027 1034 10.1007/s10552-004-1324-5